Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207167 · ClinicalTrials.gov registry record
Mediators of Atherosclerosis in South Asians Living in America
A clinical trial of Cardiovascular Diseases and Coronary Artery Disease, sponsored by University of California, San Francisco.
- Active
- Registry status
- 2,314
- Enrollment target
- 3
- Study locations
NCT01207167: Active study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by University of California, San Francisco.
NCT01207167 is a study of Cardiovascular Diseases and Coronary Artery Disease that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 2,314 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01207167, a study of Cardiovascular Diseases and Coronary Artery Disease, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 2,314 participants
- Enrollment target
- 3
- Study locations
Study Summary
South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in this high-risk ethnic group. The investigators aim to establish a longitudinal study of South Asians at three United States centers to identify risk factors linked to subclinical atherosclerosis and incident cardiovascular disease. The purpose of this study is to understand the causes of heart disease and stroke in South Asians and compare these causes to those in other United States ethnic groups.
Conditions Studied
Study Locations (3)
California
- University of California, San Francisco - San Francisco
Illinois
- Northwestern University - Chicago
New York
- New York University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,314 participants |
| Start Date | 2010-09 |
| Est. Completion | 2027-04 |
What the registry record for NCT01207167 still lists
NCT01207167 is an observational study that tracks outcomes without assigning an intervention. Its 2,314 participants enrollment target places it among the larger protocols in the corpus, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower).
The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT01207167 reports a single indexed study location in California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT01207167 about?
NCT01207167 is a clinical study titled "Mediators of Atherosclerosis in South Asians Living in America". South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in ...
What is the current status of trial NCT01207167?
This trial is currently active not recruiting. The enrollment target is 2,314 participants. The study started on 2010-09. Estimated completion is 2027-04.
What conditions does trial NCT01207167 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Atherosclerosis, Coronary Disease.
Who is sponsoring clinical trial NCT01207167?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01207167 being conducted?
This trial has 3 study locations across California, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01207167's enrollment target sits among peer trials
2,314 34th of 300 higher than 267 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia